Anaptysbio Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$59.66

+0.23 (+0.39%)

As of Jun 24, 1:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target -13.2% upside

Low Target $39.42

Average Target $51.79

High Target $66.87

Current Price $59.66

Current
$59.66

Target
$51.79

$39.42 $51.79 avg $66.87

Scenario Analysis

Bear Case

$39.42

-33.9%

Low target

Base Case

$51.79

-13.2%

Avg target

Bull Case

$66.87

+12.1%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$72.36

-17.6% from high

52-Week Low

$11.40

+423.3% from low

Target vs 52W High

$51.79

-28.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%